K&L GATES, LLP

Lobbying for BORYUNG CORPORATION · South Korean healthcare and pharmaceutical company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · $10,000.00 income · posted Apr 19, 2026

Lobbying activity 3

Aerospace

Issues related to pharmaceutical and life sciences in space.

Pharmacy

Issues related to pharmaceutical and life sciences in space.

Science/Technology

Issues related to pharmaceutical and life sciences in space.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.